Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction
Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction. JAMA 1997, 277: 115-121. DOI: 10.1001/jama.1997.03540260029031.Peer-Reviewed Original ResearchCalcium channel blockersCalcium channel blocker useΒ-blockersAdverse outcomesChannel blockersBlocker useEligible patientsMyocardial infarctionRelative riskMortality rateAcute myocardial infarction survivorsBaseline risk variablesCardiac hospital readmissionsElderly AMI survivorsΒ-blocker therapyΒ-blocker usePredictors of survivalRisk of deathRetrospective cohort designAcute myocardial infarctionDemonstrable adverse effectsMyocardial infarction survivorsNew β-blockerPrescription drug coverageMeasurable adverse outcomesAdverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997, 277: 115-21. PMID: 8990335, DOI: 10.1001/jama.277.2.115.Peer-Reviewed Original ResearchConceptsCalcium channel blockersCalcium channel blocker useAdverse outcomesChannel blockersBlocker useEligible patientsMyocardial infarctionRelative riskMortality rateAcute myocardial infarction survivorsBaseline risk variablesCardiac hospital readmissionsElderly AMI survivorsBeta-blocker therapyBeta-blocker usePredictors of survivalRisk of deathRetrospective cohort designAcute myocardial infarctionDemonstrable adverse effectsMyocardial infarction survivorsPrescription drug coverageMeasurable adverse outcomesBeta blockersElderly patients